These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31111561)

  • 21. Mucosal expression of S100A12 (calgranulin C) and S100A8/A9 (calprotectin) and correlation with serum and fecal concentrations in dogs with chronic inflammatory enteropathy.
    Heilmann RM; Nestler J; Schwarz J; Grützner N; Ambrus A; Seeger J; Suchodolski JS; Steiner JM; Gurtner C
    Vet Immunol Immunopathol; 2019 May; 211():64-74. PubMed ID: 31084897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated canine pancreatic lipase immunoreactivity concentration in dogs with inflammatory bowel disease is associated with a negative outcome.
    Kathrani A; Steiner JM; Suchodolski J; Eastwood J; Syme H; Garden OA; Allenspach K
    J Small Anim Pract; 2009 Mar; 50(3):126-32. PubMed ID: 19261082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of novel serological markers and autoantibodies in dogs with inflammatory bowel disease.
    Estruch JJ; Barken D; Bennett N; Krawiec DK; Ogilvie GK; Powers BE; Polansky BJ; Sueda MT
    J Vet Intern Med; 2020 May; 34(3):1177-1186. PubMed ID: 32282988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A scoring index for disease activity in canine inflammatory bowel disease.
    Jergens AE; Schreiner CA; Frank DE; Niyo Y; Ahrens FE; Eckersall PD; Benson TJ; Evans R
    J Vet Intern Med; 2003; 17(3):291-7. PubMed ID: 12774968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colonic nitrite and immunoglobulin G concentrations in dogs with inflammatory bowel disease.
    Gunawardana SC; Jergens AE; Ahrens FA; Niyo Y
    J Am Vet Med Assoc; 1997 Aug; 211(3):318-21. PubMed ID: 9262670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diarrheic dogs with food responsive disease or inflammatory bowel disease.
    Luckschander N; Allenspach K; Hall J; Seibold F; Gröne A; Doherr MG; Gaschen F
    J Vet Intern Med; 2006; 20(2):221-7. PubMed ID: 16594575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Clinical and laboratory outcomes.
    Pérez-Merino EM; Usón-Casaús JM; Zaragoza-Bayle C; Duque-Carrasco J; Mariñas-Pardo L; Hermida-Prieto M; Barrera-Chacón R; Gualtieri M
    Vet J; 2015 Dec; 206(3):385-90. PubMed ID: 26526522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifaximin is an effective alternative to metronidazole for the treatment of chronic enteropathy in dogs: a randomised trial.
    Menozzi A; Dall'Aglio M; Quintavalla F; Dallavalle L; Meucci V; Bertini S
    BMC Vet Res; 2016 Oct; 12(1):217. PubMed ID: 27716258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary leukotriene E4 concentrations as a potential marker of inflammation in dogs with inflammatory bowel disease.
    Im Hof M; Schnyder M; Hartnack S; Stanke-Labesque F; Luckschander N; Burgener IA
    J Vet Intern Med; 2012; 26(2):269-74. PubMed ID: 22268894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunophenotype of Peripheral Blood Lymphocytes in Dogs with Inflammatory Bowel Disease.
    Galler A; Rütgen BC; Haas E; Saalmüller A; Hirt RA; Gerner W; Schwendenwein I; Richter B; Thalhammer JG; Luckschander-Zeller N
    J Vet Intern Med; 2017 Nov; 31(6):1730-1739. PubMed ID: 28862348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of faecal microbiota and serum inflammatory markers in dogs diagnosed with chronic enteropathy or small-cell lymphoma: a pilot study.
    Kaga C; Kakiyama S; Hokkyo A; Ogata Y; Shibata J; Nagahara T; Nakazawa M; Nakagawa T; Tsujimoto H; Chambers JK; Uchida K; Matsumoto S; Kobayashi T; Tomiyasu H; Mizusawa N
    Sci Rep; 2024 Aug; 14(1):19387. PubMed ID: 39169196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of signal transducer and activator of transcription 3 in dogs with chronic inflammatory enteropathies.
    Manz A; Allenspach K; Kummer S; Richter B; Walter I; Macho-Maschler S; Tichy A; Burgener IA; Luckschander-Zeller N
    J Vet Intern Med; 2021 May; 35(3):1288-1296. PubMed ID: 33955083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized-controlled trial.
    Jergens AE; Crandell J; Morrison JA; Deitz K; Pressel M; Ackermann M; Suchodolski JS; Steiner JM; Evans R
    J Vet Intern Med; 2010; 24(2):269-77. PubMed ID: 20051005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical characterization of gastrointestinal macrophages/phagocytes in dogs with inflammatory bowel disease (IBD) and non-IBD dogs.
    Wagner A; Junginger J; Lemensieck F; Hewicker-Trautwein M
    Vet Immunol Immunopathol; 2018 Mar; 197():49-57. PubMed ID: 29475506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of assays for perinuclear antineutrophilic cytoplasmic antibodies and antibodies to Saccharomyces cerevisiae in dogs with inflammatory bowel disease.
    Allenspach K; Luckschander N; Styner M; Seibold F; Doherr M; Aeschbach D; Gaschen F
    Am J Vet Res; 2004 Sep; 65(9):1279-83. PubMed ID: 15478778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of perinuclear antineutrophil cytoplasmic antibodies and antinuclear antibodies in the diagnosis of canine inflammatory bowel disease.
    Mancho C; Sainz A; García-Sancho M; Villaescusa A; Tesouro MA; Rodríguez-Franco F
    J Vet Diagn Invest; 2010 Jul; 22(4):553-8. PubMed ID: 20622225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of clinical, clinicopathologic, and histologic variables in dogs with chronic inflammatory enteropathy and low or normal serum 25-hydroxycholecalciferol concentrations.
    Wennogle SA; Priestnall SL; Suárez-Bonnet A; Webb CB
    J Vet Intern Med; 2019 Sep; 33(5):1995-2004. PubMed ID: 31496004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral chondroitin sulfate and prebiotics for the treatment of canine Inflammatory Bowel Disease: a randomized, controlled clinical trial.
    Segarra S; Martínez-Subiela S; Cerdà-Cuéllar M; Martínez-Puig D; Muñoz-Prieto A; Rodríguez-Franco F; Rodríguez-Bertos A; Allenspach K; Velasco A; Cerón J
    BMC Vet Res; 2016 Mar; 12():49. PubMed ID: 26965834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased immunoglobulin A concentrations in feces, duodenum, and peripheral blood mononuclear cells of dogs with inflammatory bowel disease.
    Maeda S; Ohno K; Uchida K; Nakashima K; Fukushima K; Tsukamoto A; Nakajima M; Fujino Y; Tsujimoto H
    J Vet Intern Med; 2013; 27(1):47-55. PubMed ID: 23216572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypovitaminosis D in dogs with inflammatory bowel disease and hypoalbuminaemia.
    Gow AG; Else R; Evans H; Berry JL; Herrtage ME; Mellanby RJ
    J Small Anim Pract; 2011 Aug; 52(8):411-8. PubMed ID: 21797872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.